drugset / Trial / NCT04605458

Contingency Management to Promote Smoking Abstinence in Cancer Patients

NCT04605458

RandomizedParallel-groupOpen-labelTreatment

Summary

This is a smoking cessation treatment study. Patients who have a cancer or a suspected cancer who will undergo surgical removal of their cancer are eligible to participate in this study. A novel smoking cessation treatment will be provided to half of the participants in the study. All study participants will receive standard smoking cessation therapy including counseling and the nicotine patch.

Timeline

Start
2020-11-25
Primary completion
2025-07-10
Completion
2025-12-18

Drugs

EvaluationDrugModalityDoseRoute
Background Nicotine Unknown

Indications

No indication recorded.